UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Annals of the rheumatic diseases, 2015-07, Vol.74 (7), p.1474-1478

2015

Volltextzugriff (PDF)

Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials

Arthritis care & research (2010), 2019-03, Vol.71 (3), p.367-378

2019

Volltextzugriff (PDF)

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2016-07, Vol.75 (7), p.1407-1415

2016

Volltextzugriff (PDF)

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

The Lancet (British edition), 2017-06, Vol.389 (10086), p.2317-2327

2017

Volltextzugriff (PDF)

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE

Annals of the rheumatic diseases, 2015-04, Vol.74 (4), p.791-792

2015

Volltextzugriff (PDF)

The Diagnosis and Treatment of Sjögren's Syndrome

Deutsches Ärzteblatt international, 2017-05, Vol.114 (20), p.354-361

2017

Volltextzugriff (PDF)

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

Annals of the rheumatic diseases, 2022-06, Vol.81 (6), p.881-888

2022

Volltextzugriff (PDF)

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease

Annals of the rheumatic diseases, 2022-09, Vol.81 (9), p.1313-1322

2022

Volltextzugriff (PDF)

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study

The Lancet (British edition), 2016-12, Vol.388 (10061), p.2763-2774

2016

Volltextzugriff (PDF)

Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus

Annals of the rheumatic diseases, 2013-09, Vol.72 (9), p.1549-1558

2013

Volltextzugriff (PDF)

Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2

Journal of cellular biochemistry, 2007-05, Vol.101 (1), p.135-146

2007

Volltextzugriff (PDF)

Fluoreszenzoptische Bildgebung zum Nachweis einer möglichen Psoriasisarthritis im Vergleich zum muskuloskelettalen Ultraschall

Journal der Deutschen Dermatologischen Gesellschaft, 2019-09, Vol.17 (9), p.913-922

2019

Volltextzugriff (PDF)

Exogenous and Endogenous Glucocorticoids in Rheumatic Diseases

Arthritis & rheumatology (Hoboken, N.J.), 2011, Vol.63 (1), p.1-9

2011

Volltextzugriff (PDF)

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2017-10, Vol.69 (10), p.1937-1948

2017

Volltextzugriff (PDF)

A Human Osteochondral Tissue Model Mimicking Cytokine-Induced Key Features of Arthritis In Vitro

International journal of molecular sciences, 2020-12, Vol.22 (1), p.128

2020

Volltextzugriff (PDF)

Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys

Kidney international, 2021-01, Vol.99 (1), p.238-246

2021

Volltextzugriff (PDF)

Prophylactic antibodies inhibit spike‐specific T and B cell responses after COVID‐19 vaccination

Journal of medical virology, 2024-07, Vol.96 (7), p.e29778-n/a

2024

Volltextzugriff (PDF)

Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages

European journal of immunology, 2017-01, Vol.47 (1), p.180-192

2017

Volltextzugriff (PDF)

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

Annals of the rheumatic diseases, 2022-07, Vol.81 (7), p.944-950

2022

Volltextzugriff (PDF)

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab

Annals of the rheumatic diseases, 2012-01, Vol.71 (1), p.75-79

2012

Volltextzugriff (PDF)

Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study

Arthritis research & therapy, 2017-05, Vol.19 (1), p.87-87, Article 87

2017

Volltextzugriff (PDF)

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients

International journal of molecular sciences, 2017-03, Vol.18 (3), p.583-583

2017

Volltextzugriff (PDF)

Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing

International journal of molecular sciences, 2020-01, Vol.21 (3), p.865

2020

Volltextzugriff (PDF)

Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity

Arthritis research & therapy, 2018-03, Vol.20 (1), p.44-44, Article 44

2018

Volltextzugriff (PDF)

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (1), p.204-209

2010

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(182)
Life Sciences & Biomedicine
(178)
Humans
(151)
Rheumatology
(131)
Female
(77)
Male
(70)
Adult
(68)
Middle Aged
(66)
Rheumatoid Arthritis
(46)
Biological And Medical Sciences
(45)
Medical Sciences
(44)
Aged
(43)
Immunology
(31)
Treatment Outcome
(27)
Arthritis, Rheumatoid - Drug Therapy
(26)
Diseases Of The Osteoarticular System
(26)
Antirheumatic Agents - Therapeutic Use
(23)
Inflammation
(21)
Arthritis
(20)
Patients
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE

The Diagnosis and Treatment of Sjögren's Syndrome

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study

Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus

Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2

Fluoreszenzoptische Bildgebung zum Nachweis einer möglichen Psoriasisarthritis im Vergleich zum muskuloskelettalen Ultraschall

Exogenous and Endogenous Glucocorticoids in Rheumatic Diseases

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis

A Human Osteochondral Tissue Model Mimicking Cytokine-Induced Key Features of Arthritis In Vitro

Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys

Prophylactic antibodies inhibit spike‐specific T and B cell responses after COVID‐19 vaccination

Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab

Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients

Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing

Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus

Suchergebnisse filtern